Tumors can selectively inhibit T-cell function through both contact-dependent and independent mechanisms, as well as T-cell exhaustion, by upregulating PD-L1 expression on tumor cells and PD-1 and CTLA-4 expression on T cells19–21. The gene discussed is CTLA4; the disease is neoplasm.